258 related articles for article (PubMed ID: 32726984)
1. Circulating miR-16-5p, miR-92a-3p, and miR-451a in Plasma from Lung Cancer Patients: Potential Application in Early Detection and a Regulatory Role in Tumorigenesis Pathways.
Reis PP; Drigo SA; Carvalho RF; Lopez Lapa RM; Felix TF; Patel D; Cheng D; Pintilie M; Liu G; Tsao MS
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32726984
[TBL] [Abstract][Full Text] [Related]
2. MiRNA expression profiling in adenocarcinoma and squamous cell lung carcinoma reveals both common and specific deregulated microRNAs.
Petkova V; Marinova D; Kyurkchiyan S; Stancheva G; Mekov E; Kachakova-Yordanova D; Slavova Y; Kostadinov D; Mitev V; Kaneva R
Medicine (Baltimore); 2022 Aug; 101(33):e30027. PubMed ID: 35984198
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer.
Yu H; Pang Z; Li G; Gu T
J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722
[TBL] [Abstract][Full Text] [Related]
4. [Identification of differentially expressed genes between lung adenocarcinoma and squamous cell carcinoma using transcriber signature analysis].
Peng S; Li X; Liu Q; Zhang Y; Zou L; Gong X; Wang M; Ma X
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jun; 39(6):641-649. PubMed ID: 31270041
[TBL] [Abstract][Full Text] [Related]
5. Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus.
Chiam K; Mayne GC; Wang T; Watson DI; Irvine TS; Bright T; Smith LT; Ball IA; Bowen JM; Keefe DM; Thompson SK; Hussey DJ
World J Gastroenterol; 2020 May; 26(20):2570-2583. PubMed ID: 32523312
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs as molecular biomarkers for lung adenocarcinoma.
Robinson I; Bertsch A; Leithner K; Stiegler P; Olschewski H; Hrzenjak A
Cancer Biomark; 2022; 34(4):591-606. PubMed ID: 35431230
[TBL] [Abstract][Full Text] [Related]
7. A combination of four serum miRNAs for screening of lung adenocarcinoma.
Wang J; Zhang C; Peng X; Liu K; Zhao L; Chen X; Yu H; Lai Y
Hum Cell; 2020 Jul; 33(3):830-838. PubMed ID: 32388809
[TBL] [Abstract][Full Text] [Related]
8. Circulating miR-16-5p, miR-92a-3p and miR-451a are biomarkers of lung cancer in Tunisian patients.
Boutabba A; Missaoui F; Dlala A; Kamoun H; Ben Salem K; Gabsi A; Rejeb H; Letessier A; Miotto B; Marrakchi R
BMC Cancer; 2024 Apr; 24(1):417. PubMed ID: 38575987
[TBL] [Abstract][Full Text] [Related]
9. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
10. Integration of bioinformatics analysis and experimental validation identifies plasma exosomal miR-103b/877-5p/29c-5p as diagnostic biomarkers for early lung adenocarcinoma.
Wu J; Feng Z; Wang R; Li A; Wang H; He X; Shen Z
Cancer Med; 2022 Dec; 11(23):4411-4421. PubMed ID: 35585716
[TBL] [Abstract][Full Text] [Related]
11. miR-139-5p and miR-451a as a Diagnostic Biomarker in LUSC.
Gao B; Li R; Song X; Hu S; Yang F
Pharmgenomics Pers Med; 2023; 16():313-323. PubMed ID: 37063774
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Dong R; Liu J; Sun W; Ping W
Pathol Oncol Res; 2020 Jul; 26(3):1935-1945. PubMed ID: 31898160
[TBL] [Abstract][Full Text] [Related]
13. Identification of Novel Circulating miRNA Biomarkers for the Diagnosis of Esophageal Squamous Cell Carcinoma and Squamous Dysplasia.
Shen Y; Ding Y; Ma Q; Zhao L; Guo X; Shao Y; Niu C; He Y; Zhang F; Zheng D; Wei W; Liu F
Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1212-1220. PubMed ID: 30988139
[TBL] [Abstract][Full Text] [Related]
14. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
[TBL] [Abstract][Full Text] [Related]
15. Identification of reference miRNAs in plasma useful for the study of oestrogen-responsive miRNAs associated with acquired Protein S deficiency in pregnancy.
Tay JW; James I; Hughes QW; Tiao JY; Baker RI
BMC Res Notes; 2017 Jul; 10(1):312. PubMed ID: 28743297
[TBL] [Abstract][Full Text] [Related]
16. miRNA patterns in male LUSC patients - the 3-way mirror: Tissue, plasma and exosomes.
Bica C; Jurj A; Harangus A; Ciocan C; Moldovan A; Zanoaga O; Burz C; Ferracin M; Raduly L; Berindan-Neagoe I
Transl Oncol; 2024 Jun; 44():101951. PubMed ID: 38564933
[TBL] [Abstract][Full Text] [Related]
17. A panel of miRNAs derived from plasma extracellular vesicles as novel diagnostic biomarkers of lung adenocarcinoma.
Yao B; Qu S; Hu R; Gao W; Jin S; Liu M; Zhao Q
FEBS Open Bio; 2019 Dec; 9(12):2149-2158. PubMed ID: 31677346
[TBL] [Abstract][Full Text] [Related]
18. Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma.
Li J; Gu X; Gao C; Zhang J
Genet Res (Camb); 2022; 2022():5955052. PubMed ID: 36101742
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA analysis of childhood atopic dermatitis reveals a role for miR-451a.
Nousbeck J; McAleer MA; Hurault G; Kenny E; Harte K; Kezic S; Tanaka RJ; Irvine AD
Br J Dermatol; 2021 Mar; 184(3):514-523. PubMed ID: 32478410
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Survival of MicroRNAs Signatures in Non-small Cell Lung Cancer.
Chen B; Gao T; Yuan W; Zhao W; Wang TH; Wu J
J Cancer; 2019; 10(23):5793-5804. PubMed ID: 31737116
[No Abstract] [Full Text] [Related]
[Next] [New Search]
